Signal #144894 · SEC 8-K

$PCSA SEC Filing Alert & Real-Time AI Stock Impact Analysis

Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).

FAQ: $PCSA filing catalyst

Why did $PCSA trigger an AI stock catalyst alert?

$PCSA triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: -6.5/10). Headline: Processa Pharma Discloses Massive Dilution Risk: As-Converted Share Count at 309.3M. Key points: - Common shares outstanding currently at 2.8M vs. 306.5M Series A preferred shares (as-converted). - Total fully diluted share count expands to ~309.3M shares following Vidya Therapeutics acquisition. - Net proceeds of $183.3M extend cash runway into 2H 2029 for Phase 2 pipelines.

How did $PCSA stock react after the SEC filing?

After the SEC 8-K for $PCSA, observed market reaction: T0 price $1.94. Past moves do not guarantee future results.

Where can I get real-time $PCSA SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $PCSA via Telegram and the VIP Web Terminal from €10/month.

$PCSA

$PCSA – Processa Pharma Discloses Massive Dilution Risk: As-Converted Share Count at 309.3M

Processa Pharmaceuticals, Inc.

2026-11-05 00:00:00 UTC · SEC 8-K · All $PCSA

Unlocked archive · Analyzed in <2s at T0

Bearish AI Sentiment (-6.5 / 10)

Common shares outstanding currently at 2.8M vs. 306.5M Series A preferred shares (as-converted).
Total fully diluted share count expands to ~309.3M shares following Vidya Therapeutics acquisition.
Net proceeds of $183.3M extend cash runway into 2H 2029 for Phase 2 pipelines.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →